Clinical Trials
4 trialsNCT06987058 2025-09-24
ROVER-01
Ryvu Therapeutics SA
Phase 2 Not yet recruiting
NCT06397313 2025-09-23
POTAMI-61
Ryvu Therapeutics SA
Phase 2 Recruiting
NCT00384956 2016-12-12
A Phase II Study of Intravenous Azacitidine Alone in Patients With Myelodysplastic Syndromes
Washington University School of Medicine
Phase 2 Completed
NCT00533923 2016-07-18
Nonmyeloablative Allogeneic Stem Cell Transplantation From HLA-Matched Unrelated Donor for the Treatment of Hematologic Disorders
Beth Israel Deaconess Medical Center
Phase 2 Completed